Nanologica has thus far carried out twelve feasibility studies together with pharmaceutical companies. For such projects, Nanologica receives remuneration which is intended to meet the costs of the company’s work in this stage. If, after evaluation, the pharmaceutical company decides to take the project into clinical studies, the remuneration to Nanologica becomes substantially greater and is expected to greatly exceed the costs for the company’s work in this stage

About Us

Malva continuously strives to maintain leadership in all aspects of its analytical solutions portfolio

Stay Connected on:


Contact us

Please feel free to contact us at:

 This email address is being protected from spambots. You need JavaScript enabled to view it.
(+30) 210-8000904
(+30) 210-8001424
Athens: 13 Ilission, Ν. Kifissia 14564
Thessaloniki: 26 D. Glinou, 54249